Clinical trial

Study Evaluating Gerilimzumab´s Safety/Efficacy for Patients MTX or TNFα Antagonist Failed in Rheumatoid Arthritis

NCT02795299

Study summary

ClinicalTrials.gov

Study Evaluating Gerilimzumab´s Safety/Efficacy for Patients MTX or TNFα Antagonist Failed in Rheumatoid Arthritis

Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Gerilimzumab Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Methotrexate Normalized identity: methotrexate View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Folic Acid Normalized identity: folic acid View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2018-01-01

PhasePHASE2

Conditions

Rheumatoid Arthritisverified · MONDO: rheumatoid arthritis

Interventions

GerilimzumabDRUG

MethotrexateDRUG · verified · RxNorm: methotrexate

Folic AcidDRUG · verified · RxNorm: folic acid

PlaceboDRUG

Sponsors & collaborators

Bird Rock Bio, Inc.lead sponsor

Techtrials Pesquisa e Tecnologia Ltdacollaborator

Pharmagenixcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02795299 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.